| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 232 | 16.345 | 6.241 | 7.944 | 9.944 | 11.401 |
| Total Income - EUR | - | - | - | - | 232 | 16.528 | 6.241 | 7.944 | 9.944 | 12.205 |
| Total Expenses - EUR | - | - | - | - | 0 | 7.324 | 5.916 | 6.382 | 14.729 | 16.892 |
| Gross Profit/Loss - EUR | - | - | - | - | 232 | 9.204 | 325 | 1.561 | -4.785 | -4.687 |
| Net Profit/Loss - EUR | - | - | - | - | 229 | 8.713 | 138 | 1.323 | -4.785 | -4.687 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Getas Bio Fam S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 40 | 6.891 | 5.930 | 5.948 | 5.930 | 2.538 |
| Current Assets | - | - | - | - | 1.287 | 3.306 | 5.163 | 4.404 | 3.428 | 5.326 |
| Inventories | - | - | - | - | 0 | 400 | 898 | 287 | 563 | 167 |
| Receivables | - | - | - | - | 0 | 1.544 | 1.558 | 1.426 | 404 | 1.711 |
| Cash | - | - | - | - | 1.287 | 1.362 | 2.706 | 2.691 | 2.462 | 3.448 |
| Shareholders Funds | - | - | - | - | 272 | 8.980 | 8.919 | 10.131 | 5.315 | 598 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 1.056 | 1.217 | 2.173 | 221 | 4.043 | 7.265 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Getas Bio Fam S.r.l.